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Abstract
Background: Epilepsy mostly affects children in sub-Saharan Africa. However, little is known about 
the therapeutic itinerary of these children living with epilepsy (CWE). This study aims to describe the 
therapeutic itinerary of CWE in Kinshasa and to analyze its relationships with clinical features, 
behavioral problems and cognitive impairment.
Methods: This hospital-based study has included 104 CWE aged 6 to 17 years. The features of their 
therapeutic itinerary and their relationship with clinical features, behavioral problems and cognitive 
impairment were analyzed.
Results: The vast majority of CWE (87%) has started their therapeutic itinerary by the Western 
medicine. The first source of information about epilepsy as well as the type of antiepileptic treatment 
varied with the socioeconomic status of families of CWE. The total duration of the therapeutic itinerary
was shorter for the CWE who were living with both their parents (P = .038), who had generalized 
seizures (P = .0073) or who had no family history of epileptic seizures (P = .019). The CWE who had 
total behavioral problem, compared to the others, were putting more time (P = .021) to reach the CSMT
after the suspicion or the diagnostic of epilepsy. The total duration of CWE who had cognitive 
impairment (P = .021) was longer than that of CWE who had not cognitive impairment.
Conclusion: the therapeutic itinerary of CWE in Kinshasa began with Western medicine. The remainder
of this therapeutic itinerary highlights the difficulties of the primary level of the pyramid of care in the 
management of these CWE. This study also shows that the therapeutic itinerary of CWE was associated
with socioeconomic conditions, clinical features, behavioral problems and cognitive impairment.
Key words : Epilepsy; Children with epilepsy; Therapeutic itinerary; Cognitive impairment; Behavioral
problems; sub-Saharan Africa.
1. Introduction
Analysis of the therapeutic itinerary is important to understand the determinants of the quest of the care
for a disease. In sub-Saharan Africa, only a small number of studies have been devoted to the 
therapeutic itinerary of people living with epilepsy (PWE). These studies describe a therapeutic 
itinerary of PWE that passes successively or simultaneously through three types of treatment: Western 
medicine, traditional medicine and prayer [1-4].
Traditional medicine is often the first step in the quest for care of sub-Saharan Africa's PWE [2,3,5]. Its 
geographical, economic and cultural accessibility pleads in its favor [3,5]. In sub-Saharan Africa 
treatment with Western medicine is not the first choice of PWE [2,3,5,6]. Only one-third of PWE 
arriving in a neurological structure has ever received antiepileptic medication [6-8]. Although very little
documented, prayer is also used as a therapeutic means [1,2,4].
The therapeutic itinerary of PWE in sub-Saharan Africa is responsible for late arrival of patients in 
appropriate health facilities [6]. Birbeck [6] has found that the PWE in sub-Saharan Africa take up to 
4.7 years to reach an appropriate structure for the care of epilepsy. This delay has consequences on 
clinical characteristics, cognitive performances and the psychic functioning of the PWE. For children, 
for example, delay in the diagnosis, and consequently in the management of the epilepsy, aggravates it 
[9].
While epilepsy, in sub-Saharan Africa, more frequently affects children [8,10,11], we have not found 
studies specifically devoted to the therapeutic itinerary of children living with epilepsy (CWE). Thus, 
this study aims to describe the therapeutic itinerary of CWE, to identify its determinants and to analyze 
its relationships with behavior problems and cognitive impairment. This study is complementary to 
another one on behavioral problems and cognitive impairment in CWE of Kinshasa [12].
2. Methods
2.1. Nature, period of study and study setting
The present study is a cross-sectional hospital-based study. The inclusion of CWE, by a convenience 
sampling, was done in two times, from April to May 2013 and from November to December 2013. The 
'Centre de Santé Mental Telema' (CSMT or Mental Health Center Telema) located in the city of 
Kinshasa (capital of the Democratic Republic of the Congo) was the framework of this study. This 
neurological and psychiatric of ambulatory care health center is situated in the eastern part of the city 
of Kinshasa. Its geographic location, the relatively low cost of the care and the high influx of person 
with epilepsy are its main assets [12]. The CSMT performs more than 30,000 consultations annually. It 
has 2 EEG-videos and a pharmacy that sells psychotropic drugs at a low price.
2.2. Children with epilepsy
This study has included active CWE aged 6 to 17 years. These CWE had presented at least two 
unprovoked epileptic seizures separated by a 24 hours interval, the last of which had occurred in the 
last 5 years [13]. Seizures have been classified according to the recommendations of the International 
League Against Epilepsy [14]. The description of seizures was collected from eye witnesses of epileptic
seizures.
2.3. Characteristics of the therapeutic itinerary
The determinants of the therapeutic itinerary have been analyzed from four variables: the types of 
consultations prior to the first arrival at the CSMT, the first source of suspicion or of diagnosis of 
epilepsy, the type of antiepileptic treatment prior to the first consultation at the CSMT and the duration 
of the therapeutic itinerary.
The types of consultations prior to the first arrival at CSMT included Western medicine (regardless of 
care provider quality), traditional medicine and prayer. The CWE for which information were lacking 
to fit into one of these three categories were included in category named “other”.
The first source of suspicion or of diagnosis of epilepsy targeted the first source who had suspected or 
diagnosed epilepsy as the children's disease. It could be family or relatives, a care provider of Western 
medicine or a traditional healer. In this study, the family is understood in the broad sense and not in the 
sense of the nuclear family.
The type of antiepileptic treatment prior to the first consultation at the CSMT was considered. The 
types of antiepileptic treatment were including: antiepileptic drugs (AEDs), traditional therapy (TT), 
and the combination of AEDs and TT (AEDs-TT). In this study, the combination does not require the 
simultaneous use of both types of treatment.
The duration of the therapeutic itinerary was divided into three: i) the duration I : between the first 
seizure and the suspicion or the diagnosis of epilepsy; ii) the duration II : between the suspicion or the 
diagnosis of epilepsy and the first consultation at the CSMT; iii) and the total duration between the first
epileptic seizure and the first consultation at the CSMT.
2.4. Sociodemographic variables
The following variables were taken into account: the age, the gender, the family type (child living with 
both parents or other), the father's age, the mother's age, the household size, the estimation of the 
equivalent amount of money in United States dollars ($) usually spent on daily household needs and 
per household member.
2.5. Epileptic features
The following variables were considered: the age at first seizure, the history of epileptic seizure in the 
family, the type of epileptic seizures and the estimated monthly epileptic seizure frequency. The type of
epileptic seizures was dichotomized into generalized and other seizures (focal seizures and spasms). 
The unclassified crises were omitted from statistical analyzes. The monthly seizure frequency was 
categorized in two: < 2 seizures per month and ≥ 2 seizures per month.
2.6. Behavioral problems
The behavioral assessment was performed with the Asselbach child behavior checklist (CBCL). The 
behavioral problems (internalized, externalized and total) in the CWE included in this study were the 
subject of a previous publication [12].
2.7. Cognitive impairment
The cognitive performance was assessed using the short version (2 subtests) of the Wechsler Nonverbal
(WNV) scale of ability. The cognitive impairment was defined as a score of less than 70 on the WNV 
or the inability of the CWE to respond to WNV items coupled with a clinical history of intellectual 
disability. The cognitive impairment of CWE included in this study was the subject of a previous 
publication [12].
2.8. Missing data
To complete missing informations for some CWE, according to the case, we conducted telephonic calls
or we used medical files for CWE followed at the CSMT [12]. Missing data are indicated in the tables 
of results.
2.9. Statistical analyses
The analyses of the data were performed with the softwares Statistica 13 and SPSS 20. Associations 
between categorical variables were searched by the Pearson chi-square test eventually followed by 
analysis of standardized residuals as « post hoc » after Bonferroni corrections (αcor = 0,05 / (number of 
rows X number of columns)).
The normality of the quantitative data was assessed by the Shapiro test. The homoscedasticity was 
evaluated by the Levene’s test. Parametric statistical tests were used for quantitative variables that have
met at least equality of variances and did not exhibit important asymmetry. For the previous 
antiepileptic treatment and the source of the suspicion or the diagnostic of epilepsy, the means of 
groups were compared by planned orthogonal linear contrast tests (see supplemantary materials). Non-
parametric tests were performed for quantitative variables that did not meet at least the equality of 
variances or had exhibited a high asymmetry. Mann-Whitney U-tests and Kruskal Wallis test, 
eventually followed by multiple comparisons of mean ranks, and Spearman correlations were used 
depending on the situation.
The graphics have been plotted with software R 3.1.2. (R Core Team, 2014).
2.10. Ethical approval
The present research has obtained the agreement of the Ethics Committee of the School of Public 
Health of the University of Kinshasa (ESP/CE/018/13). The inclusion in the study was conditioned 
upon the signing of an informed consent form by an adult accompanying the CWE.
Results
3.1. Characteristics of CWE
This study had included 104 CWE (table 1). Their characteristics were described previously [11].
Table 1. General characteristics of CWE
Variable n (%) or mean±SD
Age, years 12.0 ± 3.2
Male 61 (58.6%)
Father’s age, years (N = 91) 48.9 ± 8.0
Mother’s age, years (N = 97) 41.5 ± 7.0
Lives with both parents (N=98) 74 (75.5%)
Size of household (N=102) 7.2 ± 2.6
Household daily expenditures, $ (N=98) 8.04 ± 4.14
Individual daily expenditures, $ (N=98) 1.24 ± 0.72
History of epileptic seizure in family 42 (40.4%)
Age of onset, (years) 6.9 ± 4.0
Generalized seizure (N = 96) 35 (36.4%)
≥ 2 seizure/month (N = 103) 59 (57.3%)
Cognitive impairment (N = 90) 66 (73.3%)
Internalized behavioral disorder 24 (23.1%)
Externalized behavioral disorder 28 (26.9%)
Total behavioral disorder 30 (28.8%)
3.2. Characteristics of the therapeutic itinerary
The diagram 1 traces and details the therapeutic itinerary of 101 CWE. The Western medicine was the 
first step of treatment for 88 (87.1%) CWE. These CWE who had started with Western medicine then 
moved on to the CSMT (35/88 or 39.8%), to a traditional healer (33/88 or 37.5%) or to a prayer (19/88 
or 21.6%). Thus, 59.1% (52/88) families of the CWE seen in the health facilities have sought thereafter
for the healing based on beliefs. Both the traditional medicine and the prayer were the first consultation
for five CWE (5.0%). The CSMT was the first step of the therapeutic itinerary for only one child living 
with epilepsy (1.0%). One of the two children who had started their therapeutic itinerary with an 
"other" structure had taken an antiepileptic drug by self-medication.
Finally, during their therapeutic itinerary, 92 (91.1%), 45 (44.6%) and 34 (33.7%) CWE have passed, 
respectively, towards the Western medicine, the traditional medicine and the prayer, before arriving at 
the CSMT. Overall, Western medicine had preceded, directly or indirectly, belief-based treatment in 67 
(66.3%) CWE, with traditional medicine for 39 (38.6%) CWE, and prayer for 28 (27.7%) CWE.
During their therapeutic itinerary, the CWE have consulted successively up to four different types of 
consultations (Table 2). Three quarters (76.3%) of the CWE had arrived at the CSMT with no suspicion
or diagnosis of epilepsy (43.3%) or with suspicion from family or relatives (33.0%). The majority 
(55.9%) of the CWE had previously received antiepileptic treatment with antiepileptic drugs (13.7%), 
traditional medicine (29.4%) or both (12.8%). Thus 26.5% of CWE had previously received 
antiepileptic drug and 42.2% a traditional treatment.
Table 2. Characteristics of the therapeutic itinerary
Variable n (%) or median (IQR)
Number of type of previous consultation (101)
- None 1 (1.0%)
- One 41 (40.6%)
- Two 39 (38.6%)
- Three 19 (18.8%)
- Four 1 (1.0%)
First source of suspicion/diagnostic (N=97)
- None 42 (43.3%)
- Family/relatives 32 (33.0%)
- Traditional healer 8 (8.2%)
- Health facilities 15 (15.5%)
Type of previous antiepileptic treatment (N=102)
- None 45 (44.1%)
- Traditional treatment 30 (29.4%)
- Antiepileptic drugs+Traditional treatment 13 (12.7%)
- Antiepileptic drugs 14 (13.7%)
Duration
- Duration I (year) 1 (0-2.5)
- Duration II (year) 0 (0-2.5)
- Total duration (years) 2 (1-6)
CSMT: Centre de Santé Mentale Telema.
The suspicion or the diagnosis of epilepsy had occurred 1 (0-2.5) year after the first seizure. Thereafter,
the CWE took less than a year (0 [0-2.5] year) to arrive at the CSMT. The total duration of the 
therapeutic itinerary, from the first epileptic seizure to the arrival to the CSMT, was 2 (1-6) years.
3.3. Reciprocal relationship between the therapeutic itinerary features
There was a statistically significant relationship between the first source of suspicion or diagnosis of 
epilepsy and the type of treatment (Khi2 = 40.4, df = 9, P = .00001; table 3). The threshold α for the 
post hoc assessment to independence deviations was of 0.05/(4X4) or 0.003125. The CWE who had 
been diagnosed by traditional healers were more likely to receive traditional treatment (P = .0000048). 
And the CWE who had been diagnosed in health facilities were more likely to receive AED alone (P = .
0026).
Table 3. First source of suspicion/diagnostic and antiepileptic treatment (with their adjusted residuals)
First source of suspicion or diagnostic
None Family/Relatives TH HF P
Antiepileptic treatment < .001
None 25 (2.9) 13 (-0.6) 0 (-2.7) 5 (-1.0)
Traditional 8 (-1.7) 11 (0.7) 8 (4.6) 1 (-2.1)
AED+Traditional treatment 1 (-2.2) 6 (1.9) 0 (-1.0) 3 (1.3)
AED 6 (0.1) 2 (-1.7) 0 (-1.2) 6 (3.0)
AED: antiepileptic drug. TH: traditional healer. HF: Health faliclity.
The duration I did not vary with the source of the suspicion or the diagnosis of epilepsy (H (3, N = 97) 
= 0.9, P = .82). There was a relationship between the source of the suspicion or the diagnosis of 
epilepsy and the duration II of the therapeutic itinerary (H (3, N = 97) = 48.7, P < .001, figure 1A). The 
group of CWE who had arrived at the CSMT without suspicion or diagnosis of epilepsy (0 (0-0) year) 
have shorter duration II than those who had the suspicion or the diagnosis by relatives or family (2 (1-
4) years, P < .000001), by traditional healer (2 (0.5-4.5) years, P = .0073) or Western medicine (1 (0-5) 
year, P = .0048). The total duration of the therapeutic itinerary was varied according to the source of 
suspicion or diagnosis of epilepsy (H (3, N = 97) = 15.2, P = .001, figure 1B). The CWE who did not 
had suspicion or diagnosis of epilepsy (1 (0-2) year) were arriving faster at the CSMT than the CWE 
for whom suspicion was emanating from family or relatives (4 (2-8) years, P = .0021).
The duration I did not vary with the type of the previous treatment (H (3, N = 102) = 3.7, P = .29). 
There was a relationship between the type of the previous treatment and the duration II of the 
therapeutic itinerary (H (3, N = 102) = 14.7, P = .002, figure 1C). The CWE who had not previously 
received antiepileptic treatment (0 (0-0) year) had a duration II shorter than the CWE treated with AED
combined to traditional treatment (2 (1-3) years; P = .041) and than the CWE treated with traditional 
treatment alone (1 (0-4) year, P = .027). The total duration was also varied with the types of 
antiepileptic treatment (H (3, N = 102) = 8.5, P = .037, figure 1D). But the multiple comparisons of 
mean ranks had fallen to found which groups were different.
3.4. Analysis of characteristic of the therapeutic itinerary according to sociodemographic 
characteristics and characteristics of epilepsy
The per capita daily expenditures of the CWE's families without suspicion nor diagnosis of epilepsy 
(1.45 ± 0.70 $) were higher (t = 2.1, P = .035, figure 2A) than those of families of the CWE who had 
been suspected or diagnosed by the traditional healers (1.00 ± 0.66 $) combined with to family or the 
relatives (1.09 ± 0.73 $).
The families of CWE previously traditionally treated had daily expenditures per household (6.42 ± 3.26
$ versus 8.80 ± 3.97 $, t = 2.4, P = .018) and per individual (0.99 ± 0.58 $ versus 1.37 ± 0.71 $, t = 2.2, 
P = .029) lower than those of previously untreated CWE (Figures 2B and 2C).
The CWE who were living with their both parents had a shorter duration I than the other CWE (1 (0-2) 
year versus 2 (1-5) years, N = 98, U = 550.5, P = .0037, figure 2D). The duration I was shorter for the 
CWE with generalized seizures than for the CWE with other types of seizures (0 (0-1) year versus 1 (0-
4) year, N = 96, U = 697.0, P = .0032, figure 2E). Duration I was negatively correlated with age at first 
epileptic seizure (ρ = -0.41, P = .000016, table 4).
Table 4. Matrix of correlations of the durations of the therapeutic itinerary
Age Age of onset DEH DEI
ρ P ρ P ρ P ρ P
Duration I 0.179 .068 -0.409 < .001 0.066 0.52 0.171 .093
Duration II 0.218 .026 -0.210 .032 -0.225 .026 -0.260 .0097
Total duration 0.329 < .001 -0.539 < .001 -0.163 .11 -0.097 .34
DEH: Daily expenditures per household. DEI: Daily expenditures per individual
The duration II was positively correlated with age (ρ = 0.22, P = .026, table 4). This duration was 
negatively correlated with the age at the first seizure (ρ = -0.21, P = .032), the family’s daily 
expenditures per household (N = 98, ρ = -0.22, P = .026) and per individual of household (N = 98, ρ = 
-0.26, P = .0097).
The total duration was shorter for CWE who were living with their both parents (2 (1-5) years versus 4 
(1.5-9) years, N = 98, U = 638.5, P = .038, figure 2F), who had generalized seizures (1 (0-4) year 
versus 3 (1-7) years, N = 96, U = 718.5, P = .0073, figure 2G) or who did not have a history of epilepsy
in their family (1 (1-5) year versus 3 (2-8) years, U = 950.0, P = .019, figure 2H). The total duration 
was positively correlated with age (ρ = 0.33, P = .00064, table 4) and negatively correlated with age at 
first epileptic seizure (ρ = -0.54, P < .000001).
3.5. Relationship between the therapeutic itinerary, the behavioral problems and the cognitive 
impairment
There was a relationship between internalized behavioral disorder and the first source of suspicion or 
diagnosis of epilepsy (Chi-square = 8.5, df = 3, P = .036; see supplemantary materials). Compared to 
other groups, the proportion of the internalized disorder was higher among the CWE who had been 
suspected of having epilepsy by family or by relatives (P = .0060; α corrected 0.05/(4X2) = 0.00625).
The CWE with a total behavioral disorder had a duration II (1.5 (0-4) year versus 0 (0-2.0) year, U = 
821.5, P = .021) greater than those of the CWE without total behavioral disorder (Figures 3A).
The CWE with cognitive impairment had a total duration longer than those of CWE who did not have 
cognitive impairment (2 (1-6) years versus 1 (0-4) years, N = 90, U = 541.0, P = .021, and figure 3B).
4. Discussion
4.1. Characteristics of the therapeutic itinerary
The first goal of this study was to describe the therapeutic itinerary of CWE. The results of this study, 
as observed by very few authors [15], have shown that the first consultation unfold mainly in a Western
medicine structure. This result is in contradiction with the vast majority of data from the sub-Saharan 
Africa literature describing therapeutic itinerary that begins with traditional medicine or prayer [1-3]. 
These studies have included only adults [1,2] or both adults and children [3]. The therapeutic itinerary 
of CWE could differ from that of adults living with epilepsy. Probably at the first consultation the CWE
are treated as suffering from others common diseases in Africa, such as cerebral malaria and 
meningoencephalitis, which can be manifested by epileptic seizures. It has been observed that some 
CWE were treated with antimalarials and/or antibiotics [7,16].
After the first type of consultation, the therapeutic itinerary was closer to that described in the sub-
Saharan Africa literature [2]. The trigger for this change would be the suspicion or the diagnosis of 
epilepsy. Indeed, in sub-Saharan Africa, Epilepsy is considered as having a spiritual origin [1,15]. In 
Kinshasa, epilepsy is described by the population as "maladi ya ndeke” (bird disease). This name does 
not apply to epileptic seizures of others clinical entities such as cerebral malaria or meningitis. Aujoulat
et al. [17] have shown that in sub-Saharan Africa the name of a disease influences the choice of the 
type of treatment. These researchers have observed that according to its name the same disease is 
treated either by Western medicine or by traditional treatment. This could explain why the families of 
children with epilepsy who had the information by the family or by the relatives had turned more often 
to traditional medicine. Conversely, families of children with epilepsy who did not suspect "maladi ya 
ndeke" as the disease of their child went to the CSMT or to other health facilities.
As elsewhere in sub-Saharan Africa, the total duration of the therapeutic itinerary of CWE observed in 
this study was very long. It was similar to the average of 2.2 years duration observed by Doumbia-
Ouattara et al. [3] in Ivory Coast. Moreover, these authors have described that PWE spend up to 3.6 
years before taking an antiepileptic drug. But the duration of the therapeutic itinerary observed in our 
study was much lower than the 4.7 years observed in Zambia [6].
This therapeutic itinerary beginning in Western medical structures and then moving on to antiepileptic 
treatments based on beliefs, highlights the inability of health facilities to diagnose and to manage 
epilepsy. This motivates the struggle of many researchers in sub-Saharan Africa for a better training of 
health care workers at the primary level of the health care pyramid [18].
4.2. Relationships between the characteristics of the therapeutic itinerary
The results of this study have shown that the characteristics of the therapeutic itinerary were closely 
associated between them. They express the different facets of the therapeutic itinerary. These 
associations could be summed up, in a simplistic way, the more the first source of information about 
the disease was not accurate, the more families consulted many actors and took different types of 
treatment and this was lengthening the time of the course before reaching a care structure, appropriate 
to manage epilepsy [1]. For example, Koba Bora et al. [7] in Lumbumbashi, another city of the DRC, 
have noted that PWE spent fifteen months between their first visit to a traditional healer and their 
arrival in an appropriate health facility. And Birbeck [6], in Zambia, has found that the 4.7 years 
average duration of therapeutic itinerary grows to 9 years for the PWE who have resorted care to 
traditional healers.
4.3. Therapeutic itinerary, sociodemographic and clinical characteristics
This study has observed, like many other studies, that the type of antiepileptic treatment was associated
with the socioeconomic conditions of the CWE's families [3,7,10,15]. The socioeconomic conditions 
were one of the main factors that were guiding the choice of the traditional treatment. Families of CWE
who had benefited from the traditional treatment had less financial means and could not equally afford 
the current antiepileptic treatment. Matonda et al. [16] have found that these CWE had clinical 
outcomes more severe than the CWE that did not received antiepileptic treatment prior their arrival at 
the CSMT.
Few factors were associated with the duration I. As observed by others authors, this duration was 
reducing with generalized seizures (9) and was increasing with an early onset [1]. The children who 
were living with both their parents had suspicion or diagnosis of epilepsy more rapidly. The reason is 
not clear to us. Perhaps the level of education would have played a role [1,3,9]. Is it because, in DRC, 
men have higher level of education than women? The CWE who were living with their fathers could 
thus receive the suspicion or diagnosis of epilepsy earlier. It may also be that keeping in touch with the 
families of both parents could increase the number of "experts" of the disease. Or the fact that the 
parents are together reduces the time for consultation and/or fundraising for CWE's care. Be that as it 
may, this has reduced the total length of the therapeutic itinerary for the children who were living with 
both parents.
In this study, several factors were associated with the duration II and the total duration of the 
therapeutic itinerary. Like other authors [1,9], this study has found that non-generalized seizures, young
age, and early onset have lengthened the therapeutic itinerary. These variables reflect the difficulty of 
diagnosing epilepsy, particularly in toddlers [9]. Moreover, at this age, many conditions, such as 
cerebral malaria and meningitis, that can also manifest themselves by epileptic seizures may have 
increased the difficulty of diagnosing epilepsy.
The existence of a family history of epilepsy had lengthened, paradoxically, the total duration of the 
therapeutic itinerary. Probably those who had a history of epilepsy in the family were wasting time 
seeking treatment based on belief. Two elements could explain this paradox. On the one hand, it is 
difficult for sub-Saharan Africans to accept the chronicity of a disease as being natural [15,17]. And on 
the other hand, a failure, real or perceived as such, of a drug treatment in the other family member 
suffering from epilepsy may explain the gravitation towards belief-based treatment [15,17]. Moreover, 
the families do not exclude that epilepsy may be cured without the use of any antiepileptic drug, 
particularly for cultural believes [10,15].
4.4. Therapeutic itinerary, behavioral problems and cognitive impairment
The results of this study showed that internalized behavioral disorders were more common among the 
CWE who had received the first information about their illness from a relative. Thus, the CWE would 
be sensitive to whoever first suspected or diagnosed their illness or to what was said to them the first 
time about epilepsy. Conversely, receiving the suspicion or the diagnosis by the different caregivers, 
from Western medicine as well as from traditional healers, does not increase the internalized behavior 
disorder more than the ignorance of the disease. These caregivers seem to be holding a communication 
or non-traumatic attitudes for the CWE. Particularly for traditional medicine, this finding echoes the 
observation of the authors who have examined the beneficial role of traditional healers on the psyche of
patients [19]. Thus, one can conclude that the traditional medicine would have no side effect on the 
psyche of CWE. But by lengthening of the duration of the therapeutic itinerary, the traditional medicine
would have side effects on the other clinical features of CWE [6,9].
In this study, the CWE with total behavior problem compared to the other CWE had great duration II 
that had impacted the total duration of the therapeutic itinerary. These relationships seem to highlight 
the crucial role of the announcement of and the period after the suspicion or the diagnosis of epilepsy. 
This goes in the same sense that the association between the internalized behavioral problem and the 
first source of suspicion or diagnosis of epilepsy. Some factors associated to duration II, example 
socioeconomic situation, have been shown to favor behavior disorders [20].
Among different characteristics of the therapeutic itinerary, only the total duration of the course was 
associated with cognitive disorder. This result is consistent with that of researchers working on the 
consequences of delayed diagnostic and management of epilepsy [9]. Nevertheless, as discussed above,
the duration of the therapeutic itinerary was associated with the other characteristics of the therapeutic 
itinerary. A small number of health actors, the lack of suspicion or diagnosis of epilepsy, and the 
absence of a prior antiepileptic treatment was reducing the length of therapeutic itinerary. Particularly 
for treatments with antiepileptic drugs and traditional, these findings are consistent with the findings of 
other researchers. People living with epilepsy lose a valuable time in medical structures and at 
traditional healers [6].
The relationship between the duration of the therapeutic itinerary with both the cognitive impairment 
and the behavioral problems is very interesting. This time was increased by, among others factors, the 
inability of the care providers of the first line to diagnose and to offer an appropriate treatment of 
epilepsy. Thus, the improvement of the ability of these care providers could reduce the occurrence of 
behavioral problems and of cognitive impairments.
4.5. Limits
This study is a hospital-based study and thus the CWE included in this study are not representative of 
all the CWE of Kinshasa. Nevertheless, most of our results are consistent with the literature data. 
Moreover, to our knowledge, this study is the first one devoted to the therapeutic itinerary of CWE. It 
raises several interrogations that could be subjects of others studies on the therapeutic itinerary of these 
children.
5. Conclusion
This study, contrariwise to the results of the vast majority of studies, has found that the therapeutic 
itinerary of the CWE has begun with Western medicine. This highlights the difficulties of the health 
structures to diagnose and to manage epilepsy. The rest of the therapeutic itinerary, with belief-based 
treatments, was similar to what is reported in the sub-Saharan literature. This therapeutic itinerary was 
closely related to the clinical characteristics and socioeconomic conditions in which live the CWE. This
therapeutic itinerary was also associated with behavioral problems and cognitive impairment.
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Fig. 1. Duration of the therapeutic itinerary according to the first source of suspicion or diagnosis of 
epilepsy and the type of antiepileptic treatment. N = none; F/R = family or relatives; TH = Traditional 
healer; WM = Western Medicine; TT = traditional treatment; AED + TT = antiepileptic drug and 
traditional treatment; AED = antiepileptic drug. *: P b .05; **: P b .01; ***: P b .001.
Fig. 2. The features of the therapeutic itinerary and sociodemographic and clinical characteristics of 
children living with epilepsy. N = none; F/R = family or relatives; T = traditional healer; WM = 
Western medicine. TT = traditional treatment; AED + TT = antiepileptic drug combined with traditional
treatment; AED = antiepileptic drug. *: P b .05; **: P b .01; ***: P b .001.
Fig. 3. Behavioral disorder, cognitive impairment, and the duration of therapeutic itinerary. *: P b .05; 
**: P b .01; ***: P b .001.
Supplementary materials
Table 1. Orthogonal linear contrast codes
Variables Contrast 1 Contrast 2 Contrast 3
Source of information
- Western medicine 3 0 0
- None -1 2 0
- Traditional healer -1 -1 1
- Family/Relatives -1 -1 -1
Antiepileptic treatment
- AED 3 0 0
- AED - Traditional -1 2 0
- Traditional Treatment -1 -1 -1
- None -1 -1 1
AED: antiepileptic drug.
Table 2. Source of suspicion or diagnostic and total behavioral problems (with their adjusted residuals)
Total behavioral problems P
Source of suspicion/diagnostic Yes No
None 8 (-0.9) 34 (0.9) .036
Family or relative 13 (2.7) 19 (-2.7)
Traditional healer 1 (-0.8) 7 (0.8)
Western medicine 1 (-1.7) 14 (1.7)
